Please use this identifier to cite or link to this item:
Title: Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study
Author: Ronda, Mar
Llop Talaverón, Josep Manuel
Fuset, Maripaz
Leiva, Elisabet
Shaw, Evelyn
Gumucio Sanguino, Victor Daniel
Diez, Yolanda
Colom, Helena
Rigo Bonnin, Raul
Puig Asensio, Mireia
Carratalà, Jordi
Padullés Zamora, Ariadna
Keywords: Farmacocinètica
Medicaments antifúngics
Antifungal agents
Issue Date: 25-Jun-2023
Publisher: MDPI AG
Abstract: Voriconazole, an antifungal agent, displays high intra- and inter-individual variability. The predictive pharmacokinetic (PK) index requires a minimum plasma concentration (C-min) in patient serum of between 1-5.5 mg/L. It is common to encounter fungal infections in patients undergoing extracorporeal membrane oxygenation (ECMO) support, and data regarding voriconazole PK changes during ECMO are scarce. Our study compared voriconazole PKs in patients with and without ECMO support in a retrospective cohort of critically-ill patients. Fifteen patients with 26 voriconazole C-min determinations in the non-ECMO group and nine patients with 27 voriconazole C-min determinations in the ECMO group were recruited. The ECMO group had lower C-min (0.38 & PLUSMN; 2.98 vs. 3.62 & PLUSMN; 3.88, p < 0.001) and higher infratherapeutic C-min values (16 vs. 1, p < 0.001) than the non-ECMO group. Multivariate analysis identified ECMO support (-0.668, CI95 -0.978--0.358) and plasma albumin levels (-0.023, CI95 -0.046--0.001) as risk factors for low C-min values. When comparing pre- and post-therapeutic drug optimisation samples from the ECMO group, the dose required to achieve therapeutic C-min was 6.44 mg/kg twice a day. Therapeutic drug optimisation is essential to improve target attainment.
Note: Reproducció del document publicat a:
It is part of: Antibiotics, 2023, vol. 12, num. 7
Related resource:
ISSN: 2079-6382
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
antibiotics-12-01100-v2.pdf608.98 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons